What is he best known for?
The fields of study he is best known for:
- Gene
- Cancer
- Internal medicine
Torben A Kruse mainly investigates Genetics, Breast cancer, Internal medicine, Gene and Cancer research.
His Breast cancer study integrates concerns from other disciplines, such as BRCA2 Protein, Ovarian cancer, Genome-wide association study and Genetic testing.
Torben A Kruse combines subjects such as Endocrinology, Oncology, Pathology, Reproducibility and Mass spectrometry with his study of Internal medicine.
His Gene research focuses on Immunology and how it relates to Phenotype.
His work carried out in the field of Cancer research brings together such families of science as Metastasis, Gene expression and Germline mutation.
He has researched Estrogen receptor in several fields, including Liver cancer, Single-nucleotide polymorphism and Gene mutation.
His most cited work include:
- Genome scan meta-analysis of schizophrenia and bipolar disorder, part III: Bipolar disorder. (536 citations)
- Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer (406 citations)
- Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk (344 citations)
What are the main themes of his work throughout his whole career to date?
The scientist’s investigation covers issues in Genetics, Internal medicine, Breast cancer, Gene and Cancer research.
His Internal medicine research includes elements of Gastroenterology, Endocrinology, Oncology and Pathology.
His work deals with themes such as Ovarian cancer, Metastasis and Gene expression profiling, which intersect with Breast cancer.
His Gene study combines topics from a wide range of disciplines, such as Immunology and Longevity.
He has included themes like Mutation, Germline mutation, BRCA2 Protein and Myelofibrosis in his Cancer research study.
His Allele research is multidisciplinary, incorporating perspectives in Bipolar disorder and Genotype.
He most often published in these fields:
- Genetics (35.98%)
- Internal medicine (25.30%)
- Breast cancer (23.48%)
What were the highlights of his more recent work (between 2015-2021)?
- Internal medicine (25.30%)
- Cancer research (19.21%)
- Oncology (19.51%)
In recent papers he was focusing on the following fields of study:
His primary areas of study are Internal medicine, Cancer research, Oncology, Breast cancer and Pathology.
His studies examine the connections between Internal medicine and genetics, as well as such issues in Gastroenterology, with regards to Recombinant interferon, Clinical trial and Discontinuation.
His study in Cancer research is interdisciplinary in nature, drawing from both Cell growth, Gene expression profiling, Mutation, Gene and Interferon.
His Oncology research incorporates elements of Cancer, Concordance, Biomarker, Primary tumor and Cohort.
In his work, Exome sequencing is strongly intertwined with Metastasis, which is a subfield of Breast cancer.
His Germline mutation research is under the purview of Genetics.
Between 2015 and 2021, his most popular works were:
- Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer (155 citations)
- Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer. (149 citations)
- Evaluation of Nine Somatic Variant Callers for Detection of Somatic Mutations in Exome and Targeted Deep Sequencing Data. (105 citations)
In his most recent research, the most cited papers focused on:
- Gene
- Cancer
- Internal medicine
Torben A Kruse focuses on Internal medicine, Breast cancer, Oncology, Pathology and Genetics.
His Internal medicine research focuses on Allele and how it connects with Immunology.
His work in the fields of Breast cancer, such as Estrogen receptor, overlaps with other areas such as Risk assessment.
The concepts of his Oncology study are interwoven with issues in Genetic predisposition, Biopsy, Primary tumor, Cohort and Risk factor.
Torben A Kruse combines subjects such as Phenotype, Cancer research, Microglia and Stem cell marker with his study of Pathology.
The various areas that Torben A Kruse examines in his Cancer study include Exome sequencing and Deep sequencing.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
